UA89766C2 - Transdermal delivery system of gestodene - Google Patents

Transdermal delivery system of gestodene

Info

Publication number
UA89766C2
UA89766C2 UAA200607580A UAA200607580A UA89766C2 UA 89766 C2 UA89766 C2 UA 89766C2 UA A200607580 A UAA200607580 A UA A200607580A UA A200607580 A UAA200607580 A UA A200607580A UA 89766 C2 UA89766 C2 UA 89766C2
Authority
UA
Ukraine
Prior art keywords
patch
gestodene
hormones
administering
containing layer
Prior art date
Application number
UAA200607580A
Other languages
English (en)
Ukrainian (uk)
Inventor
Штефан Брахт
Михаэль Диттген
Петра Хубер
Томас Ланггут
Дирк Шенк
Original Assignee
Байер Шеринг Фарма Акциенгезельшафт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34924031&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA89766(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Байер Шеринг Фарма Акциенгезельшафт filed Critical Байер Шеринг Фарма Акциенгезельшафт
Publication of UA89766C2 publication Critical patent/UA89766C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Botany (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Изобретение относится к медицине и касается пластыря, который включает слой, содержащий лекарственное средство с низким содержанием гестодена и необязательно эстрогена, где носитель выбран из группы, которая состоит из полиизобутиленов, полибутенов, полиизопренов, полистиренов, блок-сополимеров стирена изопрена стирена, блок-сополимеров стирена бутадиена стирена и их смесей. При использовании пластыря для женщины достигаются уровни концентрации гестодена в плазме крови, по крайней мере, 1,0 нг/мл в условиях стабильного состояния, без необходимости введения в слой, содержащий лекарственное средство, агентов, способствующих всасыванию, или агентов, усиливающих проникновение.
UAA200607580A 2003-12-12 2004-10-12 Transdermal delivery system of gestodene UA89766C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03078881 2003-12-12

Publications (1)

Publication Number Publication Date
UA89766C2 true UA89766C2 (en) 2010-03-10

Family

ID=34924031

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200607580A UA89766C2 (en) 2003-12-12 2004-10-12 Transdermal delivery system of gestodene

Country Status (24)

Country Link
EP (2) EP1541137B1 (ru)
CN (1) CN101843603B (ru)
AR (1) AR046762A1 (ru)
AT (1) ATE457168T1 (ru)
CR (1) CR8465A (ru)
CY (2) CY1110637T1 (ru)
DE (1) DE602004025444D1 (ru)
DK (2) DK2138169T3 (ru)
ES (2) ES2340925T3 (ru)
GT (1) GT200400262A (ru)
HK (2) HK1074801A1 (ru)
HN (1) HN2004000526A (ru)
HR (2) HRP20100254T1 (ru)
JO (1) JO2606B1 (ru)
ME (1) ME01069B (ru)
MY (2) MY144053A (ru)
PE (1) PE20051035A1 (ru)
PL (2) PL1541137T3 (ru)
PT (2) PT1541137E (ru)
RS (2) RS51260B (ru)
SI (2) SI1541137T1 (ru)
SV (1) SV2006001970A (ru)
TW (1) TWI257299B (ru)
UA (1) UA89766C2 (ru)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL219030B1 (pl) 2003-02-21 2015-03-31 Schering Ag Transdermalny system terapeutyczny w postaci plastra odporny na działanie promieniowania UV
US8668925B2 (en) 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
US8962013B2 (en) 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
DE102005050729A1 (de) * 2005-10-19 2007-04-26 Schering Ag Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption
CA2740002C (en) 2008-10-08 2016-11-01 Agile Therapeutics, Inc. Transdermal delivery
CA2740005C (en) 2008-10-08 2016-11-01 Agile Therapeutics, Inc. Transdermal delivery
EP2343964A4 (en) 2008-10-08 2012-11-07 Agile Therapeutics Inc TRANSDERMAL ADMINISTRATION
US9198920B2 (en) 2009-03-27 2015-12-01 Agile Therapeutics, Inc. Contraceptive transdermal delivery of hormones
DE102010040299A1 (de) * 2010-09-06 2012-03-08 Bayer Schering Pharma Aktiengesellschaft Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner)
AU2015203180B2 (en) * 2010-09-06 2016-06-30 Bayer Intellectual Property Gmbh Transdermal therapeutic systems with crystallization-inhibiting protective film (release liner)
PT2613772T (pt) 2010-09-06 2017-03-06 Bayer Ip Gmbh Emplastros transdérmicos de dose baixa com alta libertação de fármaco
US20130195956A1 (en) * 2012-01-27 2013-08-01 Agile Therapeutics, Inc. Transdermal Hormone Delivery

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081537A (en) 1975-10-10 1978-03-28 Schering Aktiengesellschaft Δ15 -Steroids and pharmaceutical compositions thereof
EP0573133A1 (de) * 1988-10-27 1993-12-08 Schering Aktiengesellschaft Mittel zur transdermalen Applikation das Gestoden enthält
AU657502B2 (en) 1990-10-29 1995-03-16 Alza Corporation Transdermal contraceptive formulations, methods and devices
US5512292A (en) * 1990-10-29 1996-04-30 Alza Corporation Transdermal contraceptive formulations methods and devices
DE4336557C2 (de) 1993-05-06 1997-07-17 Lohmann Therapie Syst Lts Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
DE4329242A1 (de) * 1993-08-26 1995-03-02 Schering Ag Mittel zur transdermalen Applikation enthaltend Gestodenester
DE4405898A1 (de) * 1994-02-18 1995-08-24 Schering Ag Transdermale therapeutische Systeme enthaltend Sexualsteroide
US5762956A (en) 1996-04-24 1998-06-09 Rutgers, The State University Of New Jersey Transdermal contraceptive delivery system and process
DE19906152B4 (de) 1999-02-10 2005-02-10 Jenapharm Gmbh & Co. Kg Wirkstoffhaltige Laminate für Transdermalsysteme
DE60043621D1 (de) 1999-11-24 2010-02-11 Agile Therapeutics Inc Verbessertes transdermales verabreichungssystem zur empfängnisverhütung und verfahren
DE10053375C1 (de) * 2000-10-27 2002-01-24 Lohmann Therapie Syst Lts Transdermale therapeutische Systeme mit lichtempfindlichen Wirkstoffen
TWI287455B (en) * 2000-12-05 2007-10-01 Noven Pharma Crystallization inhibition of drugs in transdermal drug delivery systems and methods of use

Also Published As

Publication number Publication date
AR046762A1 (es) 2005-12-21
JO2606B1 (en) 2011-11-01
RS53182B (en) 2014-06-30
HK1132682A1 (en) 2010-03-05
ME01069B (me) 2012-10-20
PT1541137E (pt) 2010-05-17
PL1541137T3 (pl) 2010-07-30
HRP20100254T1 (hr) 2010-06-30
MY144053A (en) 2011-08-15
ES2340925T3 (es) 2010-06-11
SI1541137T1 (sl) 2010-06-30
CY1115064T1 (el) 2016-12-14
TWI257299B (en) 2006-07-01
SV2006001970A (es) 2006-02-16
TW200528073A (en) 2005-09-01
EP2138169A3 (en) 2011-04-06
EP2138169A2 (en) 2009-12-30
HRP20140077T1 (hr) 2014-02-28
EP1541137B1 (en) 2010-02-10
EP1541137A3 (en) 2005-11-16
CN101843603B (zh) 2012-06-27
CR8465A (es) 2007-06-06
DK1541137T3 (da) 2010-04-26
EP1541137A2 (en) 2005-06-15
HK1074801A1 (en) 2005-11-25
ES2445690T3 (es) 2014-03-04
DE602004025444D1 (de) 2010-03-25
CN101843603A (zh) 2010-09-29
RS51260B (sr) 2010-12-31
MY152750A (en) 2014-11-28
PT2138169E (pt) 2014-02-17
EP2138169B1 (en) 2013-11-06
HN2004000526A (es) 2010-02-01
ATE457168T1 (de) 2010-02-15
PE20051035A1 (es) 2006-02-08
DK2138169T3 (da) 2013-11-18
CY1110637T1 (el) 2015-04-29
GT200400262A (es) 2005-10-31
SI2138169T1 (sl) 2014-03-31
PL2138169T3 (pl) 2014-04-30

Similar Documents

Publication Publication Date Title
MY152750A (en) Transdermal delivery system of hormones without penetration enhancers
AU4451101A (en) Method and compositions for preventing hormone induced adverse effects
PT836506E (pt) Penso transdermico para administracao de 17-desacetil norgestimato so ou em combinacao com um estrogenio
MXPA05006169A (es) Composiciones y metodos para el suministro de agentes farmacologicos.
HUP0204137A2 (hu) Fulvesztrantot tartalmazó gyógyászati készítmény
KR890011585A (ko) 경피식 피임약제제형
RS20060348A (en) Extended use combination comprising estrogens and progestins
CU20100143A7 (es) Hormonas de administración transdérmica que no necesitan potenciadores de penetración
WO1992020377A1 (en) Skin permeation enhancer compositions using glycerol monolinoleate
TW200514560A (en) Pharmaceutical formulation for contraception and hormone-replacement therapy
MXPA04005211A (es) Sistemas terapeuticos transdermicos que contienen hormona esteroides y monocaprilato de propilenglicol.
AU3601897A (en) Novel formulations for the administration of fluoxetine
YU13902A (sh) Mezoprogestini (progesteron receptor modulatori) kao komponente kontraceptivnih sredstava za žene
MXPA05003364A (es) Parche transdermico de 17(-estradiol/levonorgestrel para hormonoterapia restitutiva.
AU5105699A (en) Formulations for the transdermal administration of fenoldopam
TH115856B (th) การนำส่งฮอร์โมนผ่านผิวหนังโดยไม่ต้องการสารเพิ่มการแทรกซึม
CU20060121A7 (es) Hormonas de administración transdérmica que no necesitan potenciadores de penetración
UY28668A1 (es) Hormonas de administración transdérmica que no necesitan potenciadores de penetración
MX9709872A (es) Formulaciones novedosas para suministro transdermico de pergolide.